Brief: Kinnate Biopharma Inc. Enters Into Agreement To Be Acquired By Xoma Corporation

Xoma Royalty

16/02/2024 14:26

Feb 16 (Reuters) - Kinnate Biopharma Inc  KNTE.O :
    * KINNATE BIOPHARMA INC. ENTERS INTO AGREEMENT TO BE
ACQUIRED BY
XOMA CORPORATION FOR BETWEEN $2.3352 AND $2.5879 PER SHARE IN
CASH, PLUS ONE CONTINGENT VALUE RIGHT PER SHARE
    * UNIT OF XOMA WILL COMMENCE TENDER OFFER BY MARCH 4 TO
ACQUIRE
ALL OUTSTANDING SHARES OF KINNATE COMMON STOCK

Source text for Eikon:  ID:nGNX1sdRvl 
Further company coverage:  KNTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))